tiprankstipranks
Advertisement
Advertisement

BPH Global Plans Major Share and Option Issue to Boost Capital Base

Story Highlights
  • BPH Global plans to issue up to 500 million new fully paid ordinary shares.
  • The company will also issue 250 million options at $0.004, expiring in three years, to bolster funding.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
BPH Global Plans Major Share and Option Issue to Boost Capital Base

Claim 30% Off TipRanks

Stemcell United Ltd. ( (AU:BP8) ) just unveiled an announcement.

BPH Global Ltd, listed on the ASX under code BP8, is an Australia-registered company; the announcement does not specify its industry, products, or market focus. The company has notified the ASX of a proposed capital raising via the issue of up to 500 million new fully paid ordinary shares and 250 million options exercisable at $0.004 over three years, with the issue scheduled for 12 February 2026, a move that will significantly increase its capital base and potentially dilute existing shareholders while providing additional funding for its activities.

The most recent analyst rating on (AU:BP8) stock is a Sell with a A$0.06 price target. To see the full list of analyst forecasts on Stemcell United Ltd. stock, see the AU:BP8 Stock Forecast page.

More about Stemcell United Ltd.

BPH Global Ltd, listed on the ASX under code BP8, is an Australia-registered company; the announcement does not specify its industry, products, or market focus.

Current Market Cap: A$3.71M

See more data about BP8 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1